Tofflon Science and Technology Co., Ltd. logo

Tofflon Science and Technology Co., Ltd. (300171)

Market Open
11 Aug, 06:57
XSHE XSHE
¥
13. 07
-0.05
-0.3811%
¥
12.27B Market Cap
- P/E Ratio
0.12% Div Yield
4.29M Volume
- Eps
¥ 13.12
Previous Close
Add Transaction
Day Range
12.96 13.15
Year Range
10.42 20.37
Want to track 300171 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

300171 trading today lower at ¥13.07, a decrease of -0.3811% from yesterday's close, completing a monthly increase of 17.536% or ¥1.95. Over the past 12 months, 300171 stock lost -17.6952%.
300171 pays dividends to its shareholders, with the most recent payment made on Jun 01, 2026. The next estimated payment will be in In 3 months on Dec 01, 2026 for a total of ¥0.08.
The last earnings report, released on Apr 29, 2026, missed the consensus estimates by -0.15%. On average, the company has fell short of earnings expectations by -0.0012%, based on the last three reports.
Tofflon Science and Technology Co., Ltd. has completed 4 stock splits, with the recent split occurring on Jun 19, 2015.
The company's stock is traded on one exchange.

300171 Chart

People also search for

ZTE Corporation
¥ 34.5
+0.5831%
Boe Technology Group Co., Ltd.
5.14 HKD
+0.3906%
Hithink RoyalFlush Information Network Co., Ltd.
¥ 240.64
+0.893%
Lens Technology Co., Ltd.
¥ 34.67
-0.6306%
BOE Technology Group Co., Ltd.
¥ 5.96
+1.1885%

Tofflon Science and Technology Co., Ltd. (300171) FAQ

What is the stock price today?

The current price is ¥13.07.

On which exchange is it traded?

Tofflon Science and Technology Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 300171.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.12%.

What is its market cap?

As of today, the market cap is 12.27B.

Has Tofflon Science and Technology Co., Ltd. ever had a stock split?

Tofflon Science and Technology Co., Ltd. had 4 splits and the recent split was on Jun 19, 2015.

Tofflon Science and Technology Co., Ltd. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Mr. Xiaodong Zheng CEO
XSHE Exchange
CNE100000ZP0 ISIN
CN Country
5,417 Employees
1 Jun 2026 Last Dividend
9 Jul 2014 Last Split
1 Feb 2011 IPO Date

Overview

Tofflon Science and Technology Group Co., Ltd., initially established as Shanghai Tofflon Science and Technology Co., Ltd., has carved a niche as a prestigious pharmaceutical equipment supplier serving the pharma and biotech sectors globally since its inception in 1993. Headquartered in Shanghai, China, the company specializes in a vast range of products and solutions aimed at revolutionizing pharmaceutical production processes. The company's dedication to innovation, quality, and service has positioned it as a leader in providing cutting-edge equipment and systems for various pharmaceutical applications.

Products and Services

Below are the detailed offerings by Tofflon Science and Technology Group Co., Ltd.:

  • Injectables:

    This includes a comprehensive suite of solutions like auto solution preparation systems, aseptic filling lines for ampoules, vials, syringes, powders, freeze dryers, and auto loading systems. These technologies ensure sterile processing, enhancing the safety and efficacy of injectable pharmaceutical products.

  • Barrier Systems:

    Designed to safeguard the sterility and integrity of pharmaceutical products, these systems play a pivotal role in preventing contamination and ensuring product safety throughout the manufacturing process.

  • Plastic Packaging Machines:

    Tofflon offers advanced plastic packaging solutions tailored to meet the specific needs of the pharmaceutical and biotech industries, ensuring durability, safety, and compliance with regulatory standards.

  • Active Pharmaceutical Ingredients (APIs):

    The company provides essential ingredients required for drug formulation, emphasizing purity, efficiency, and consistency to meet the stringent quality demands of the pharmaceutical industry.

  • Visual Inspection, Leak Detection, and Combination Systems:

    These systems are crucial for ensuring the quality and integrity of pharmaceutical products by identifying defects, ensuring proper sealing, and verifying product combinations for compliance with industry standards.

  • Bio-Process Equipment and Integrated Systems:

    Encompassing a range of services from medium preparation, cell/microbial cultivation, harvesting, DF/UF (diafiltration/ultrafiltration), purification, buffer preparation to finished filling systems, Tofflon's offerings cater to the upstream and downstream processes in biopharmaceutical production.

  • Lyophilization Injectable Lab Services:

    These services focus on the freeze-drying technique, a critical process in the pharmaceutical industry for extending the shelf life of products, especially injectables, by removing water from the product under low temperature and vacuum.

Contact Information

Address: Building 4, Shanghai, China, 201108
Phone: 86 21 6490 9699